Java SE Advanced and its sibling SKUs were Oracle's commercial Java products before the subscription era. Knowing what they covered, and why Oracle retired them, tells you what your old entitlement is and is not worth in 2026.
Java SE Advanced and the older Java SKUs were retired and folded first into the Java SE Subscription and then into the per employee Universal Subscription. A surviving perpetual entitlement still carries usage rights worth documenting.
Before Oracle sold Java as a subscription, it sold it as a set of named products. Java SE Advanced was the most common commercial tier. It bundled the Java runtime with commercial features such as advanced monitoring and management tooling, along with the right to receive updates and support. There were related SKUs, including a higher tier that added more tooling, and the products were licensed on the metrics of their day, Named User Plus and per processor.
For a decade these products were how an enterprise paid for supported, commercially licensed Java. If your organization bought Java in that era, there is a good chance Java SE Advanced or one of its siblings sits in your entitlement records, and that record still matters.
Oracle simplified its Java commercial lineup in stages. The named product SKUs gave way to the Java SE Subscription, a per user and per processor subscription introduced in 2018 and 2019. Then in January 2023 Oracle replaced that with the Universal Subscription, priced on the per employee metric that counts every full time and part time employee, every contractor, and every temporary worker. Each step moved Java further from the deployment based pricing of the old products toward pricing on your headcount.
The commercial logic is plain. The older products priced what you ran. The Universal Subscription prices who you employ, which for most enterprises is a far larger number. Retiring the named SKUs removed the cheaper, deployment based options from the price list.
The other event that shapes a legacy Java SE Advanced position is the end of free public updates for Java SE 8 in April 2019. Before that date, Java SE updates were effectively free for most commercial use, and many organizations never bought a commercial product at all. After it, staying current on Java SE 8 in production required either a commercial subscription or a move to a free OpenJDK distribution. A Java SE Advanced entitlement was one way enterprises kept receiving updates across that boundary.
The figures below are indicative and exist to show the direction of change, not to predict your result.
| Era | Product | Priced on |
|---|---|---|
| Before 2018 | Java SE Advanced and siblings | NUP and processor |
| 2018 to 2022 | Java SE Subscription | User and processor |
| 2023 onward | Universal Subscription | Per employee |
Each row prices Java on a broader base than the one before. That is why a surviving older entitlement, valued on a narrower base, can still be worth defending.
If you bought Java SE Advanced as a perpetual license, you retain the right to use the versions you licensed under the terms you agreed, even though the product is no longer sold and your support may have lapsed. That right does not entitle you to new updates, but it can cover existing deployments without a move to the employee metric. If you held it as a subscription, the rights ended with the term. Reading your paperwork to tell which case applies is the first step, and it mirrors the work in keeping legacy Java licensing in play in 2026.
Where the old entitlement does not cover a deployment, the buyer side answer is to migrate that deployment to a free OpenJDK distribution rather than accept a workforce wide subscription. For how to make that move without surrendering value, see our guide to migrating from a legacy Java metric.
The value of a Java SE Advanced entitlement lives in the wording of the agreement you signed, so that is where to start. Three things decide what you can do today. The license type tells you whether you bought a perpetual right or a term subscription, and only the perpetual right survives the end of payments. The metric, Named User Plus or per processor, tells you how the entitlement is counted and therefore how much deployment it covers. And the version scope tells you which releases of Java SE you may run under it, which matters because a perpetual license covers the versions you licensed rather than every version Oracle later shipped.
Reading those three elements correctly often changes the picture. A buyer who assumed an old Java SE Advanced purchase was worthless may find a perpetual, per processor right that covers a live deployment outright. A buyer who assumed broad coverage may find the version scope is narrower than the releases now in production. Either way, the agreement, not the sales conversation, governs.
Java SE Advanced bundled commercial features alongside the runtime, including advanced monitoring and management tooling. Two questions follow for a buyer. First, are you actually using those commercial features, or only the base runtime? Many organizations bought the bundle but rely only on standard Java, which means a free OpenJDK distribution can cover the deployment without losing anything in use. Second, where a commercial feature is genuinely in use, is there a free or alternative path, or does that specific workload need a current Oracle subscription? Separating the features you use from the ones you merely licensed is often the difference between a large subscription and a small residual.
Three misconceptions cost buyers money. The first is that retiring a product cancels existing perpetual rights. It does not. Oracle stopped selling Java SE Advanced, but a perpetual license you already hold remains a usage right. The second is that the move to the Universal Subscription automatically converts old entitlements into the employee metric. It does not. Conversion is a commercial proposal you can accept, decline, or scope down, not an automatic upgrade. The third is that lapsed support voids the license. It does not void the right to run the versions you licensed, it only ends new updates. Clearing these three misconceptions usually reveals more room to maneuver than a buyer expected.
Once you have read the agreement and separated the features you use from the ones you merely licensed, the decision usually resolves into three paths. Where a perpetual right covers a live deployment on a version you still run, keep that deployment on the licensed version and document the cover. Where the deployment only needs the base runtime, migrate it to a free OpenJDK distribution and retire the dependency on a commercial product altogether. And where a workload genuinely needs a current Oracle feature or current updates, isolate it and license only that small residual rather than the whole estate.
The thread through all three is that an old Java SE Advanced purchase is a starting position, not a dead end. Read correctly, it either covers a deployment outright, points to a free replacement, or shrinks the residual you must license today. Each of those outcomes keeps you off a workforce wide subscription, which for most enterprises is the most expensive answer on the table.
A perpetual Java SE Advanced license is a usage right Oracle no longer sells. Document the versions and quantities it covers, keep those deployments on licensed versions, and migrate the rest rather than upgrading the whole company to the employee metric.
Java SE Advanced is gone from the price list, but a perpetual entitlement to it is not gone from your rights. Read the agreement, separate the license to use from lapsed support, and use what you own to cap exposure. For the full picture of how the metric and the audit fit together, read our Oracle Java licensing guide for 2026.
Download our Oracle Java licensing guide for 2026 to map old entitlements against the employee metric before your next audit or renewal.
Download the guideFixed fee or gainshare, both backed by our guarantee. We sit between you and Oracle and we never take vendor money.
Get a QuoteWeekly intelligence on Oracle Java licensing moves and the buyer side defenses that work.